|
1
|
Al-Attar A, Mess S, Thomassen JM, Kauffman
CL and Davison SP: Keloid pathogenesis and treatment. Plast
Reconstr Surg. 117:286–300. 2006. View Article : Google Scholar
|
|
2
|
Atiyeh BS, Costagliola M and Hayek SN:
Keloid or hypertrophic scar: the controversy: review of the
literature. Ann Plast Surg. 54:676–680. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Estrem SA, Domayer M, Bardach J and Cram
AE: Implantation of human keloid into athymic mice. Laryngoscope.
97:1214–1218. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pierce HE: Keloids: enigma of the plastic
surgeon. J Natl Med Assoc. 71:1177–1180. 1979.PubMed/NCBI
|
|
5
|
Huang C, Akaishi S, Hyakusoku H and Ogawa
R: Are keloid and hypertrophic scar different forms of the same
disorder? A fibroproliferative skin disorder hypothesis based on
keloid findings. Int Wound J. Nov 22–2012.(Epub ahead of
print).
|
|
6
|
de Mesquita CJ: About strawberry, crab
claws, and the Sir James Black’s invention. Hypothesis: can we
battle keloids with propranolol? Med Hypotheses. 74:353–359.
2010.PubMed/NCBI
|
|
7
|
Akaishi S, Ogawa R and Hyakusoku H: Keloid
and hypertrophic scar: neurogenic inflammation hypotheses. Med
Hypotheses. 71:32–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alonso PE, Rioja LF and Pera C: Keloids: A
viral hypothesis. Med Hypotheses. 70:156–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O’Brien L and Jones DJ: Silicone gel
sheeting for preventing and treating hypertrophic and keloid scars.
Cochrane Database Syst Rev. 9:Sep 12–2013.(Epub ahead of
print).
|
|
10
|
Kischer CW, Shetlar MR and Chvapil M:
Hypertrophic scars and keloids: a review and new concept concerning
their origin. Scan Electron Microsc. 4:1699–1713. 1982.PubMed/NCBI
|
|
11
|
Tredget EE, Nedelec B, Scott PG and
Ghahary A: Hypertrophic scars, keloids, and contractures. The
cellular and molecular basis for therapy. Surg Clin North Am.
77:701–730. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sandulache VC, Parekh A, Li-Korotky H,
Dohar JE and Hebda PA: Prostaglandin E2 inhibition of keloid
fibroblast migration, contraction, and transforming growth factor
(TGF)-beta 1-induced collagen synthesis. Wound Repair Regen.
15:122–133. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Clark RA: Cutaneous tissue repair: basic
biologic considerations. I J Am Acad Dermatol. 13:701–725. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sahl WJ Jr and Clever H: Cutaneous scars:
Part I. Int J Dermatol. 33:681–691. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nakaoka H, Miyauchi S and Miki Y:
Proliferating activity of dermal fibroblasts in keloids and
hypertrophic scars. Acta Derm Venereol. 75:102–104. 1995.PubMed/NCBI
|
|
16
|
Nedelec B, Shankowsky H, Scott PG, Ghahary
A and Tredget EE: Myofibroblasts and apoptosis in human
hypertrophic scars: the effect of interferon-alpha2b. Surgery.
130:798–808. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marneros AG and Krieg T: Keloids -
clinical diagnosis, pathogenesis, and treatment options. J Dtsch
Dermatol Ges. 2:905–913. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ladin DA, Hou Z, Patel D, et al: p53 and
apoptosis alterations in keloids and keloid fibroblasts. Wound
Repair Regen. 6:28–37. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Messadi DV, Le A, Berg S, et al: Effect of
TGF-beta 1 on PDGF receptors expression in human scar fibroblasts.
Front Biosci. 3:a16–a22. 1998.PubMed/NCBI
|
|
20
|
Sayah DN, Soo C, Shaw WW, et al:
Downregulation of apoptosis-related genes in keloid tissues. J Surg
Res. 87:209–216. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujiwara M, Muragaki Y and Ooshima A:
Keloid-derived fibroblasts show increased secretion of factors
involved in collagen turnover and depend on matrix
metalloproteinase for migration. Br J Dermatol. 153:295–300. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calderon M, Lawrence WT and Banes AJ:
Increased proliferation in keloid fibroblasts wounded in vitro. J
Surg Res. 61:343–347. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moon JH, Kwak SS, Park G, et al: Isolation
and characterization of multipotent human keloid-derived
mesenchymal-like stem cells. Stem Cells Dev. 17:713–724. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen W, Fu X, Sun X, et al: Analysis of
differentially expressed genes in keloids and normal skin with cDNA
microarray. J Surg Res. 113:208–216. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Messadi DV, Doung HS, Zhang Q, et al:
Activation of NFkappaB signal pathways in keloid fibroblasts. Arch
Dermatol Res. 296:125–133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tosa M, Ghazizadeh M, Shimizu H, et al:
Global gene expression analysis of keloid fibroblasts in response
to electron beam irradiation reveals the involvement of
interleukin-6 pathway. J Invest Dermatol. 124:704–713. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ehrlich HP, Desmouliere A, Diegelmann RF,
et al: Morphological and immunochemical differences between keloid
and hypertrophic scar. Am J Pathol. 145:105–113. 1994.PubMed/NCBI
|
|
28
|
Szulgit G, Rudolph R, Wandel A, et al:
Alterations in fibroblast alpha1beta1 integrin collagen receptor
expression in keloids and hypertrophic scars. J Invest Dermatol.
118:409–415. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alster TS and Tanzi EL: Hypertrophic scars
and keloids: etiology and management. Am J Clin Dermatol.
4:235–243. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tuan TL and Nichter LS: The molecular
basis of keloid and hypertrophic scar formation. Mol Med Today.
4:19–24. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Q, Oh CK, Messadi DV, et al:
Hypoxia-induced HIF-1 alpha accumulation is augmented in a
co-culture of keloid fibroblasts and human mast cells: involvement
of ERK1/2 and PI-3K/Akt. Exp Cell Res. 312:145–155. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Harty M, Neff AW, King MW and Mescher AL:
Regeneration or scarring: an immunologic perspective. Dev Dyn.
226:268–279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Makino S, Mitsutake N, Nakashima M, et al:
DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I
collagen accumulation in keloid fibroblasts. J Dermatol Sci.
51:171–180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
De Bosscher K, Schmitz ML, Vanden Berghe
W, et al: Glucocorticoid-mediated repression of nuclear
factor-kappaB-dependent transcription involves direct interference
with transactivation. Proc Natl Acad Sci USA. 94:13504–13509.
1997.
|
|
35
|
Yin MJ, Yamamoto Y and Gaynor RB: The
anti-inflammatory agents aspirin and salicylate inhibit the
activity of IκB kinase-β. Nature. 396:77–80. 1998.
|
|
36
|
Gilmore TD and Herscovitch M: Inhibitors
of NF-kappaB signaling: 785 and counting. Oncogene. 25:6887–6899.
2006. View Article : Google Scholar : PubMed/NCBI
|
